Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC] - N0000193808

Pharmacologic Code	N0000193808
Pharmacologic Name	Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
Pharmacologic Uses	CD4-directed post-attachment HIV-1 inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	62064-122	Trogarzo	Non-Proprietary Name: Ibalizumab	Injection, Solution	Intravenous	Theratechnologies Inc.	ACTIVE